Abstract P4-08-01: Assessing the safety and feasibility of efficient hypothesis testing in patients with metastatic triple negative breast cancer

C. Anthony Blau(University of Washington), Jingchun Zhu(University of California System), Wayne L. Monsky(University of Washington), Jeannine S. McCune(City of Hope), Jennifer M. Specht(University of Washington), Julie R. Gralow(American Society of Clinical Oncology), Frank M. Senecal(Northwest Medical Specialties), Mary Goldman(University of California System), Nathan D. Price(Buck Institute for Research on Aging), Nicole M. Kuderer, Eric Kladjian(Incyte (United States)), William Stafford Noble(University of Washington), Jackie L. Stilwell(ViaCyte (United States)), Colin C. Pritchard(Animal and Plant Health Agency), Sibel Blau(University of Washington Tacoma), Carla Grandori(Precision for Medicine (United States)), Elisabeth Mahen(University of Washington), Linda Dhaene(Northwest Medical Specialties), David Haussler(Santa Cruz County Office of Education), Kimberly A. Burton(University of Washington), Michael O. Dorschner(University of Washington), Brigham H. Mecham(Boston University), Arturo B. Ramirez, VK Gadi(University of Washington), Carol Collins(Incyte (United States)), Chao-Zhong Song(University of Washington), Aime Radenbaugh(University of California System)
Cancer Research
May 1, 2015
Cited by 0


Related Papers